| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.009 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |